Abstract
To evaluate the safety and effectiveness of THC:YAG laser sclerostomy in reducing intraocular pressure (IOP), we performed 16 subconjunctival sclerostomies under a partial-thickness corneal flap. We report the 3- and 6-month follow-up results in these patients, all of whom had intractable glaucoma resistant to previous surgical treatment. The mean IOP decreased from a pretreatment value of 30 mm Hg to a posttreatment value of 14 mm Hg at 3 months. Fifty-seven percent of the treated eyes achieved an IOP below 20 mm Hg at 6 months. A significant reduction in glaucoma medications is also reported among the successes. Complications were minimal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
